Detalles de la búsqueda
1.
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Br J Cancer
; 130(6): 934-940, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243011
2.
Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithm.
BMC Med Res Methodol
; 23(1): 276, 2023 11 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001421
3.
Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis.
Int J Gynecol Cancer
; 32(12): 1583-1591, 2022 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36028235
4.
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.
Int J Gynecol Cancer
; 29(9): 1381-1388, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31685557
5.
TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice.
Cancers (Basel)
; 16(6)2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539483
6.
Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy.
Front Immunol
; 14: 1236965, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37744323
7.
Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas.
J Neurosurg Sci
; 67(1): 55-65, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33056947
8.
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
JAMA Oncol
; 9(2): 225-233, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520422
9.
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model.
Pharmaceutics
; 14(4)2022 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35456521
10.
Experiences and well-being of healthcare professionals working in the field of ultrasound in obstetrics and gynaecology as the SARS-CoV-2 pandemic were evolving: a cross-sectional survey study.
BMJ Open
; 12(2): e051700, 2022 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121598
11.
Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model.
Front Med (Lausanne)
; 9: 995325, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300186
12.
Type of chemotherapy has substantial effects on the immune system in ovarian cancer.
Transl Oncol
; 14(6): 101076, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770618
13.
Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer.
Cancers (Basel)
; 13(23)2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885008
14.
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study.
Cells
; 9(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012728
15.
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
BMJ
; 370: m2614, 2020 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732303
16.
Trial watch: dendritic cell vaccination for cancer immunotherapy.
Oncoimmunology
; 8(11): e1638212, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646087
17.
Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer.
Anticancer Res
; 39(11): 5953-5962, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31704820
Resultados
1 -
17
de 17
1
Próxima >
>>